top of page
APEXELL
Global leader in IPRs of Human Disease
APEXELL Co., Ltd
Global Leader in IPRs of Human Disease
Apexell specializes in intellectual property rights related to human diseases. It holds domestic and foreign patents for special substances related to anticancer drugs, and is leaping forward as a global company through R&D using experts and legal review of patents.
SEPTEMBER, 2021
Apexell corporation was established, and detailed discussions about clinical trials are in progress with Mahindra Group in India for the anticancer drug business. And in contact with a global pharmaceutical company for the final purpose of licensing out.
JULY, 2021
Based on the fact that the substance crosses the brain's BBB, Apexell's research team embarked on basic research into the treatment of brain-related diseases.
bottom of page